ClinicalKey AI

What is ClinicalKey AI?

ClinicalKey AI is Elsevier’s conversational assistant layered over ClinicalKey, its large licensed library of books, journals, drug monographs, guidelines, and multimedia. It launched in the United States on February 29, 2024, originally developed in partnership with OpenEvidence. Unlike open-web assistants, it restricts answers to that vetted, licensed corpus and returns citations traceable to the paragraph level, with clinician-in-the-loop review.

What is ClinicalKey AI best at?

• Licensed depth with traceable citations. Answers are grounded in a large, named, licensed corpus rather than the open web, and citations trace to the specific paragraph, which suits clinicians and librarians who need to verify a source.
• Fits the Elsevier ecosystem. EHR and single-sign-on integration, plus in-platform CME and MOC credit, make it a natural fit for institutions already standardized on Elsevier.
• Institutional incumbency. A long-standing presence across hospital systems and medical schools.

What are ClinicalKey AI’s limitations?

• Paid, and mostly institutional. It is a paid product: institutional licensing plus individual subscriptions (monthly or annual) with a 14-day trial that auto-converts to paid. Most clinicians reach it only through an academic or hospital library.
• Ecosystem-dependent. Independent reviews position it as best for clinicians already embedded in Elsevier, and less compelling otherwise.
• Guideline alignment. It is not aligned to UK NICE or SIGN guidance, a limitation for UK-based practice.

Who is ClinicalKey AI best for?

Academic medical centers, residency programs, and clinicians who already work inside the Elsevier ecosystem and value licensed depth, paragraph-level citations, and in-workflow CME and MOC. Clinicians without institutional access, or who need a free tool available worldwide, will be better served elsewhere; for a free, source-traceable evidence engine see our Vera Health review.